Dissecting NF-κB signaling induced by genotoxic agents via genetic complementation of NEMO-deficient 1.3E2 cells

Methods Mol Biol. 2015:1280:197-215. doi: 10.1007/978-1-4939-2422-6_11.

Abstract

The transcription factor NF-κB regulates expression of a diverse set of genes to modulate multiple biological and pathological processes. Among these, NF-κB activation in response to genotoxic agents has received considerable attention due to its role in regulating cancer cell resistance to chemo- and radiation therapy. Furthermore, induction of this pathway by endogenous damage is further implicated in normal developmental processes, such as B cell development, and premature aging, among others. This pathway also serves as a signaling model in which nuclear initiated signals (DNA damage) are communicated to a cytoplasmic target (IκB kinase and NF-κB). Several of the critical molecular events of this nuclear to cytoplasmic NF-κB signaling cascade were discovered, in part, by genetic complementation analyses of the NEMO-deficient 1.3E2 mouse pre-B cell line. This chapter describes methods used to generate and analyze such reconstitution cell systems and certain caveats that are critical for proper interpretation of NEMO mutant defects.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Culture Techniques
  • Cell Line, Transformed
  • DNA Damage
  • Electrophoretic Mobility Shift Assay / methods
  • Genetic Complementation Test
  • Intracellular Signaling Peptides and Proteins / deficiency*
  • Mice
  • Mutagens / pharmacology*
  • Mutation
  • NF-kappa B / metabolism*
  • Precursor Cells, B-Lymphoid / metabolism*
  • Signal Transduction / drug effects*

Substances

  • Intracellular Signaling Peptides and Proteins
  • Mutagens
  • NEMO protein, mouse
  • NF-kappa B